A Study to Determine the Safety and Immunogenicity of Bivalent GI.1 and GII.4 Vaccines in Healthy Volunteers

Clinical trial NCT05626803 · COMPLETED

Trial details

NCT number: NCT05626803
Sponsor: Vaxart
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Norovirus Infections

Start date: 2023-01-26
Primary completion: 2023-10-16
Enrollment: 135

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.